s-nitroso-n-acetylpenicillamine has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danser, AH; de Vries, R; Dekker, R; Duncker, DJ; Eringa, EC; Koopmans, SJ; Sorop, O; van Beusekom, HM; van den Heuvel, M; van der Giessen, WJ | 1 |
| Hong, CY; Hsiao, M; Kok, SH; Kuo, MY; Lin, CT; Lin, LD; Lin, SK; Wang, CC | 1 |
2 other study(ies) available for s-nitroso-n-acetylpenicillamine and Disease Exacerbation
| Article | Year |
|---|---|
Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes.
Topics: Animals; Blood Glucose; Bradykinin; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Progression; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Male; Nitric Oxide; Nitric Oxide Donors; Receptors, Endothelin; S-Nitroso-N-Acetylpenicillamine; Swine; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2012 |
Nitric oxide promotes the progression of periapical lesion via inducing macrophage and osteoblast apoptosis.
Topics: Animals; Apoptosis; Cell Line; Cells, Cultured; Disease Models, Animal; Disease Progression; Drug Synergism; Enzyme Inhibitors; Free Radical Scavengers; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Osteoblasts; Periapical Diseases; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Small Interfering; S-Nitroso-N-Acetylpenicillamine | 2007 |